Drug Information

Drug General Information
Drug ID
D0B1IC
Former ID
DIB007423
Drug Name
CR8020 mab
Drug Type
Antibody
Indication Influenza virus [ICD10:J11.1] Phase 2 [524539]
Company
Crucell
Target and Pathway
Target(s) Hemagglutinin Target Info [532953]
References
Ref 524539ClinicalTrials.gov (NCT01992276) Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection. U.S. National Institutes of Health.
Ref 532953Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. J Virol. 2014 Dec;88(23):13580-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.